
|Articles|October 20, 2015
Efficacy of Ozurdex in DME in the real world clinical setting-Leowenstein interview
Professor Anat Lowenstein talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.
Advertisement
Redirect to video article
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
2
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
3
Novel therapy for incision-free keratoconus: Q&A with Gloria B. Chiu, OD, FAAO, FSLS
4
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
5

















































.png)


